<DOC>
	<DOCNO>NCT00540163</DOCNO>
	<brief_summary>This observational non-interventional study design demonstrate improvement physical function COPD patient exercise-induced dyspnoea treatment Spiriva ( tiotropium 18 Âµg capsule ) allow adverse event record evaluate .</brief_summary>
	<brief_title>Observational Non-interventional Study With Spiriva Chronic Obstructive Pulmonary Disease Patients With Exercise-induced Dyspnoea</brief_title>
	<detailed_description>Study Design :</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Dyspnea</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Men woman COPD thoracic gas volume ( TGV ) &lt; 140 % rest , MRC value 2 . Patients recruit general specific contraindication list Patient information leaflet Summary Product Characteristics applies . Tiotropium bromide inhalation powder contraindicate patient hypersensitivity tiotropium bromide , atropine derivative , e.g . ipratropium oxitropium excipient lactose monohydrate contains milk protein .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>